LaCroix A Z, Wienpahl J, White L R, Wallace R B, Scherr P A, George L K, Cornoni-Huntley J, Ostfeld A M
Epidemiology, Demography, and Biometry Program, National Institute on Aging, Bethesda, Md.
N Engl J Med. 1990 Feb 1;322(5):286-90. doi: 10.1056/NEJM199002013220502.
Thiazide diuretic agents lower the urinary excretion of calcium. Their use has been associated with increased bone density, but their role in preventing hip fracture has not been established. We prospectively studied the effect of thiazide diuretic agents on the incidence of hip fracture among 9518 men and women 65 years of age or older residing in three communities. At base line, 24 to 30 percent of the subjects were thiazide users. In the subsequent four years, 242 subjects had hip fractures. The incidence rates of hip fracture were lower among thiazide users than nonusers in each community; the Mantel-Haenszel relative risk of hip fracture, adjusted for community and age, was 0.63 (95 percent confidence interval, 0.46 to 0.86). The protective effect of the use of thiazides was independent of sex, age, impaired mobility, body-mass index, and current and former smoking status; the multivariate adjusted relative risk of hip fracture was 0.68 (95 percent confidence interval, 0.49 to 0.94). Furthermore, the protective effect was specific to thiazide diuretic agents, since there was no association between the use of antihypertensive medications other than thiazides and the risk of hip fracture. These prospective data suggest that in older men and women the use of thiazide diuretic agents is associated with a reduction of approximately one third in the risk of hip fracture.
噻嗪类利尿剂可降低尿钙排泄。其使用与骨密度增加有关,但在预防髋部骨折方面的作用尚未确定。我们前瞻性地研究了噻嗪类利尿剂对居住在三个社区的9518名65岁及以上男性和女性髋部骨折发生率的影响。在基线时,24%至30%的受试者使用噻嗪类药物。在随后的四年中,242名受试者发生了髋部骨折。在每个社区中,噻嗪类药物使用者的髋部骨折发生率低于非使用者;经社区和年龄调整后,Mantel-Haenszel髋部骨折相对风险为0.63(95%置信区间为0.46至0.86)。使用噻嗪类药物的保护作用与性别、年龄、行动不便、体重指数以及当前和以前的吸烟状况无关;多变量调整后的髋部骨折相对风险为0.68(95%置信区间为0.49至0.94)。此外,这种保护作用是噻嗪类利尿剂所特有的,因为使用除噻嗪类以外的抗高血压药物与髋部骨折风险之间没有关联。这些前瞻性数据表明,在老年男性和女性中,使用噻嗪类利尿剂可使髋部骨折风险降低约三分之一。